In our previous post on how to avoid initial denials of reimbursement claims for viscosupplementation, we discuss how the demand for osteoarthritis therapy viscosupplementation has been rising and will continue [...]

Currently, nearly 23% of adults older than 40 have knee osteoarthritis. As the American population ages and gains weight, the demand for osteoarthritis therapy viscosupplementation has risen rapidly. Market forecasters [...]